Should Investors Get Out Of Oshkosh (OSK) Before Carl Icahn Does?

Page 1 of 2

ICAHN CAPITAL LPIt appears that Carl Icahn has given up on Oshkosh Corporation (NYSE:OSK). The 13D that Icahn filed with the SEC earlier this week showed that he had sold off over 1.2 million shares, dropping his stake in the company to 8.1% from 9.5%. This drove the stock down as much as 7%. Icahn’s hopes of turning around the company appears to be diminished as he failed to get 22% of the company’s shares tendered to him, below the 25% threshold that he wanted for extending the offer and moving forward with a proxy contest. The billionaire activist investor has been showing interest in other stocks he has been building a position in (see Carl Icahn’s newest bets here).

Icahn has been a large shareholder of the equipment maker Oshkosh since 2011 and has been in a heated battle to have new members elected to the board. This would be just one stepping stone to what many believe is Icahn’s plan to break the company into a defense and a construction equipment company. Shortly after Icahn took a 10% stake in Oshkosh last year, he took a noticeable stake in Navistar International Corp (NYSE:NAV). The idea is that with enough pressure, Icahn could convince the two companies to merge their defense units.

Icahn had been unsuccessful in electing six board candidates to the board earlier this year and upped his efforts by offering $32.50 per share – a 20% premium at the time – for the over 90% of Oshkosh shares he did not already own in an effort to get his candidates on the board. Icahn has called for a more aggressive growth strategy, believing that management has underachieved that implementing new initiatives at the company.

Bank of America analysts and Oshkosh’s management rebutted Icahn’s offer as undervaluing the equipment company, though, so there were mixed feelings to say the least. We believe that potential Oshkosh investors might fall into a so-called value trap, where the stock’s valuation looks attractive, but there are bearish fundamental issues at play. The industrial company appears to trade below many of its major peers at 10x earnings, but we believe this sub-industry average P/E is warranted.

Icahn does not always succeed, as exhibited by exits from Clorox and Commercial Metals after unsuccessful bid attempts. Since Icahn started removing himself from these companies they have both underperformed the broader market, as measured by the S&P 500. Clorox is up only 9% versus the S&P that is up 17%, and Commercial Metals is down 9% compared to the S&P that is up 9%.

There still appears to be significant risk in Oshkosh’s defense segment and the equipment company will now have to rely heavily on its commercial segment. Revenues are expected to be down 7% in 2013 due to a sharp decline in defense demand. Oshkosh’s recently quarterly results showed that the vehicle manufacturer beat estimates of $0.47 by posting $0.71; even so, backlog was down heavily, 38% year over year and 13% quarter over quarter. This downfall in backlog was mainly driven by weakness in the access equipment business, which was expected to carry the company, down 50% year over year and 51% quarter over quarter.

Although some analysts and management still attach an undervalued status on Oshkosh based on a sum-of-the-parts valuation, the reality remains that to effectively break up the company there would need to be a buyer. There are limited parties interested who could get enough synergistic value to pay the premium that management is expecting. We believe that although the Oshkosh-Navistar segment merger might not come to fruition, Navistar could serve as a better standalone investment.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!